Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South Korea
Latest Information Update: 06 May 2021
At a glance
- Drugs Nonacog gamma (Primary)
- Indications Haemophilia B
- Focus Adverse reactions
- Sponsors Baxalta; Shire; Takeda
- 30 Apr 2019 Status changed from recruiting to completed.
- 06 Dec 2016 Status changed from not yet recruiting to recruiting.
- 12 Oct 2016 New trial record